Disrupted white matter microstructural integrity of type 2 diabetes mellitus with mild cognitive impairments

Xianxian Zhou1, Jiehuan Wang2, Xueyong Yang1

  • 1Department of Medical Imaging, Zoucheng People's Hospital, Zoucheng 273500, Shandong Province, China.

Neuroscience
|June 14, 2026
PubMed

Insights

Type 2 diabetes mellitus (T2DM) is linked to brain changes affecting cognition. This study reveals white matter alterations in T2DM patients with mild cognitive impairment, correlating with cognitive decline.

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Endocrinology

Background:

  • Type 2 diabetes mellitus (T2DM) is a common condition often associated with cognitive impairments.
  • Understanding the underlying neural mechanisms of cognitive decline in T2DM is crucial for early intervention.

Purpose of the Study:

  • To investigate white matter microstructural changes in individuals with T2DM and mild cognitive impairment (T2DM-MCI).
  • To correlate these microstructural changes with cognitive performance and blood glucose levels.

Main Methods:

  • Employed Neurite Orientation Dispersion and Density Imaging (NODDI) to assess white matter microstructure.
  • Included three groups: T2DM-MCI (n=16), T2DM with normal cognition (T2DM-NC, n=36), and healthy controls (HC, n=29).
  • Utilized cognitive assessments and correlational analysis.

Main Results:

  • Both T2DM-MCI and T2DM-NC groups exhibited reduced neurite density index (NDI) and increased orientation dispersion index (ODI) and free water fraction (FWF) compared to HC in key white matter tracts.
  • The T2DM-MCI group showed significantly higher ODI and FWF than the T2DM-NC group.
  • White matter alterations in T2DM-MCI significantly correlated with cognitive scores and blood glucose levels.

Conclusions:

  • T2DM is associated with widespread white matter microstructural abnormalities, even in individuals with normal cognition.
  • T2DM-MCI is characterized by more pronounced white matter changes, contributing to cognitive impairments.
  • These findings enhance the understanding of the neural basis of early cognitive dysfunction in T2DM.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...